[ad_1]
A week ago, Spanish health authorities announced that valsartan a drug used by hypertensive patients was contaminated with a carcinogenic substance. After this announcement, 22 countries have launched health alerts for people who use this drug to talk to their doctors and change the drug.
Research determined that the contamination of valsartan was due to a change in the way in which they manufactured the drug, a substance known as NMDA was formed
"NDMA or N-nitrosodimethylamine is classified Although the Spanish Agency for Medicines and Health Products has stated that the amount of this carcinogenic substance is very low, it is obvious that no one should be unnecessarily exposed to this drug, "explained Elmer Huerta, RPP Medical Consultant
The NDMA is a substance that, when it enters the human body, attacks the liver region and, in in some cases, it is associated with lung cancer and internal bleeding.
EL VALSARTÁN IN PERU
This 12th of July, the Directorate General of Drugs, Supplies and Drugs ( Digemid ) immobilized 104 lots of 33 products with valsartan which will be withdrawn from the national market
The agency also recommended that doctors – with patients requiring this type of medication – be able to substitute their doses by other drugs to
"I am d & # 39; An agreement with Digemid to recommend to patients not to interrupt their treatment and to consult their doctor or pharmacist to inform them if their medications are withdrawn from the market. and replace it with a drug from another batch that is not contaminated with NDMA, "added the specialist.
Source link
